Stockscreener 앱 받기
3.49
4.90%
-0.18
시간 외 거래:
3.51
0.02
+0.57%
전일 마감가:
$3.67
열려 있는:
$3.7
하루 거래량:
423.31K
Relative Volume:
0.60
시가총액:
$108.32M
수익:
$80.97M
순이익/손실:
$-78.31M
주가수익비율:
-0.3148
EPS:
-11.0849
순현금흐름:
$-129.56M
1주 성능:
+19.11%
1개월 성능:
-16.90%
6개월 성능:
+73.63%
1년 성능:
+101.73%
1일 변동 폭
$3.465
$3.70
1주일 범위
$3.00
$3.80
52주 변동 폭
$1.325
$4.53
Fortress Biotech Inc Stock (FBIO) Company Profile
명칭
Fortress Biotech Inc
전화
781-652-4500
주소
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Compare FBIO vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
3.49 | 113.91M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-15 | 재개 | ROTH MKM | Buy |
| 2022-08-04 | 개시 | Ladenburg Thalmann | Buy |
| 2020-10-02 | 개시 | The Benchmark Company | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2018-02-28 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | 개시 | Rodman & Renshaw | Buy |
| 2017-03-22 | 개시 | JMP Securities | Mkt Outperform |
| 2016-10-03 | 개시 | ROTH Capital | Buy |
모두보기
Fortress Biotech Inc 주식(FBIO)의 최신 뉴스
Fortress Biotech (NASDAQ:FBIO) Shares Cross Above 200-Day Moving AverageWhat's Next? - MarketBeat
Wall Street Recap: How do insiders feel about Fortress Biotech IncDividend Hike & Trade Opportunity Analysis - baoquankhu1.vn
Exit Recap: Is Fortress Biotech Inc part of any ETFPortfolio Performance Summary & Long Hold Capital Preservation Tips - baoquankhu1.vn
Fortress Biotech, Inc. (NASDAQ:FBIO) Might Not Be As Mispriced As It Looks After Plunging 28% - 富途牛牛
Market Cool On Fortress Biotech, Inc.'s (NASDAQ:FBIO) Revenues Pushing Shares 28% Lower - simplywall.st
Fortress Biotech (NASDAQ:FBIO) Shares Jump Above Average Bulls Prepare For Follow Through - Kalkine Media
Fortress Biotech (NASDAQ:FBIO) Shares Pass Above 200-Day Moving AverageWhat's Next? - MarketBeat
Fortress Biotech amends credit agreement with Oaktree - MSN
(FBIOP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Fortress Biotech (NASDAQ:FBIOP) Shares Down 4.7% – What’s Next? - Defense World
Fortress Biotech Leads High-Performing Stocks with 93.1% Return - Markets Mojo
Aug Technicals: Can Fortress Biotech Inc deliver alpha2025 Growth vs Value & Weekly Momentum Picks - baoquankhu1.vn
Fortress Biotech (NASDAQ:FBIO) Stock Price Crosses Above 200 Day Moving AverageHere's What Happened - MarketBeat
Fortress Biotech (NASDAQ:FBIO) Stock Price Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World
ETF Watch: How liquid is OS Therapies Incorporated stockIPO Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
How (FBIOP) Movements Inform Risk Allocation Models - Stock Traders Daily
Fortress Biotech, Inc. (NASDAQ:FBIO) Could Be Less Than A Year Away From Profitability - Yahoo Finance
Zacks Research Upgrades Fortress Biotech (NASDAQ:FBIO) to Strong-Buy - MarketBeat
Analysts Issue Forecasts for FBIO FY2025 Earnings - Defense World
Fortress Bio gains on FDA approval of copper replacement therapy - MSN
Research Analysts Set Expectations for FBIO FY2025 Earnings - MarketBeat
FBIO Stock Surges 12% Pre-Market After It Wins FDA Approval For Rare Pediatric Menkes Disease - Stocktwits
Risk Hedge: What are the risks of holding Fortress Biotech IncGap Down & Low Risk Entry Point Guides - baoquankhu1.vn
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO, the First and Only Approved Treatment for Menkes Disease in the United States - marketscreener.com
US FDA approves Fortress Bio and Zydus’ treatment for a rare pediatric disease - whtc.com
Investors Purchase Large Volume of Fortress Biotech Call Options (NASDAQ:FBIO) - MarketBeat
Fortress Biotech (FBIO) Surges After FDA Approval for Zycubo - GuruFocus
US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease - Reuters
Fortress Biotech Gains FDA Approval for Menkes Treatment - TipRanks
Fortress Bio wins FDA nod for Menkes disease drug (FBIO:NASDAQ) - Seeking Alpha
Fortress Biotech and Cyprium Therapeutics Announce U.S. Fda Approval of Zycubo - marketscreener.com
FDA Approves Fortress Biotech's ZYCUBO for Pediatric Menkes Dise - GuruFocus
Fortress Biotech, Cyprium Say FDA Approved Zycubo for Pediatric Patients of Menkes Disease; Shares Rise Pre-Bell - marketscreener.com
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States - The Manila Times
Fortress Biotech and Cyprium Therapeutics Announce FDA Approval of ZYCUBO for Menkes Disease and Transfer of Rare Pediatric Disease Priority Review Voucher from Sentynl Therapeutics - Quiver Quantitative
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA - GlobeNewswire
Fortress Biotech's Subsidiary Nears Key FDA Decision, Shares Rise 3% - Intellectia AI
Trading Systems Reacting to (FBIOP) Volatility - Stock Traders Daily
Fortress Biotech (NASDAQ:FBIOP) Shares Up 2.4% – Should You Buy? - Defense World
Will Fortress Biotech Inc.(CNB0) stock rise with strong economyMarket Sentiment Summary & Risk Managed Investment Signals - Улправда
Fortress Biotech (NASDAQ:FBIO) Stock Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Aug Rallies: Can Fortress Biotech Inc. stock hit record highs againBond Market & AI Optimized Trade Strategies - Улправда
Will Fortress Biotech Inc. stock benefit from AI adoptionOptions Play & Short-Term Trading Alerts - ulpravda.ru
Can Fortress Biotech Inc. stock hit record highs againMarket Movement Recap & Daily Profit Maximizing Tips - Улправда
How Fortress Biotech Inc. stock compares to industry benchmarksJobs Report & Real-Time Buy Signal Alerts - ulpravda.ru
Will Fortress Biotech Inc. stock outperform international peersJuly 2025 Review & Expert Verified Stock Movement Alerts - Улправда
Is Fortress Biotech Inc.(CNB0) stock testing key supportWeekly Investment Report & Stepwise Entry/Exit Trade Alerts - Улправда
Fortress Biotech (NASDAQ: FBIO) reports 13.4% Avenue (ATXI) stake with voting control - Stock Titan
Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc. - 富途牛牛
Head-To-Head Comparison: Fortress Biotech (NASDAQ:FBIO) & WAVE Life Sciences (NASDAQ:WVE) - Defense World
Avenue Therapeutics Provides Regulatory Update on IV Tramadol and Other Corporate Updates - ADVFN
Fortress Biotech Inc (FBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.19%
자본화:
|
볼륨(24시간):